Benzinga | Nov 5, 2020 08:09AM EST

Akebia Therapeutics Q3 EPS $(0.42) Misses $(0.17) Estimate, Sales $60.00M Miss $84.90M Estimate

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.17) by 147.06 percent. This is a 8.7 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $60.00 million which missed the analyst consensus estimate of $84.90 million by 29.33 percent. This is a 34.77 percent decrease over sales of $91.98 million the same period last year.